The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

Veure altres versions (1)

Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...

Descripció completa

Dades bibliogràfiques
Autors principals:	Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D
Format:	Conference item
Publicat:	Springer London 2018

Ítems similars

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
per: Ali, M, et al.
Publicat: (2018)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
per: Ali, MS, et al.
Publicat: (2017)

Oral bisphosphonates and chronic kidney disease: progression and safety
per: Prieto-Alhambra, D, et al.
Publicat: (2018)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
per: Alarkawi, D, et al.
Publicat: (2018)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
per: Robinson, DE, et al.
Publicat: (2021)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
per: Strauss, V, et al.
Publicat: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
per: Robinson, DE, et al.
Publicat: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
per: Robinson, DE, et al.
Publicat: (2021)

Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
per: Alarkawi, D, et al.
Publicat: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
per: Ali, M, et al.
Publicat: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
per: Danielle E Robinson, et al.
Publicat: (2021-03-01)

Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
per: Veronika Kreutle, et al.
Publicat: (2014-06-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
per: Hawley, S, et al.
Publicat: (2014)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
per: Ryan Jalleh, et al.
Publicat: (2018-01-01)

Denosumab and chronic kidney disease: Severe life-threatening hypocalcaemia
per: Pilar Monge Rafael, et al.
Publicat: (2018-01-01)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
per: Prieto-Alhambra, D, et al.
Publicat: (2014)

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
per: Ali, MS, et al.
Publicat: (2020)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
per: Abrahamsen, B, et al.
Publicat: (2016)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
per: Oda, T, et al.
Publicat: (2021)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
per: Round, G, et al.
Publicat: (2012)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
per: Round, G, et al.
Publicat: (2012)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
per: Reyes, C, et al.
Publicat: (2015)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
per: Prieto-Alhambra, D, et al.
Publicat: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
per: Prieto-Alhambra, D, et al.
Publicat: (2012)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
per: Jean-Jacques Body, et al.
Publicat: (2018-09-01)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
per: Rodriguez, AJ, et al.
Publicat: (2020)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
per: Garriga, C, et al.
Publicat: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
per: Garriga, C, et al.
Publicat: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
per: Garriga, C, et al.
Publicat: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
per: Garriga, C, et al.
Publicat: (2017)

Vitamin D repletion and aromatase inhibitor-related bone loss in women non treated with bisphosphonates
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
per: Khalid, S, et al.
Publicat: (2021)

HYPOCALCAEMIA – CASE REPORT
per: Tina Svetlik, et al.
Publicat: (2022-03-01)

Pseudohypoparathyroidism, Rare Cause of Hypocalcaemia!
per: Rupal V. Dosi, et al.
Publicat: (2013-10-01)